A carregar...
P03.08 Pathological Analysis of Xenografts with Malignant Glioma After Anti-angiogenic Therapy
Introduction: Malignant gliomas are known to secrete high levels of vascular endothelial growth factor (VEGF). Bevacizumab, which is a monoclonal antibody to VEGF, has demonstrated convincing therapeutic benefits in patients with glioblastoma. However, several reports have shown that anti-VEGF thera...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463698/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.123 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|